Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel

Background, aims: Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used adjunctively following such debridement. This 2‐centre study compared the clinical effects of subgingival scaling (SRP) with S...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of clinical periodontology Ročník 27; číslo 12; s. 910 - 917
Hlavní autoři: Griffiths, G. S., Smart, G. J., Bulman, J. S., Weiss, G., Shrowder, J., Newman, H. N.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Copenhagen Munksgaard International Publishers 01.12.2000
Témata:
ISSN:0303-6979, 1600-051X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background, aims: Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used adjunctively following such debridement. This 2‐centre study compared the clinical effects of subgingival scaling (SRP) with SRP plus subgingival application of 25% metronidazole gel, Elyzol® (SRP+gel), in patients with chronic adult periodontitis. Method: Voluntary informed written consent was obtained from 45 subjects at the Eastman (mean age 46, range 34–63) and 43 subjects at RAF Halton (mean age 47, range 34–71) who participated in this blind, randomised split‐mouth design study. All had at least 2 sites in each quadrant with probing pocket depth (PPD) 5 mm. PPD, bleeding on probing (BOP), and clinical probing attachment levels (CAL) measured using a stent, were recorded at baseline and at 1, 3, 6 and 9 months post‐therapy. After subgingival scaling of all quadrants, 2 quadrants were randomly selected to be treated with metronidazole gel. Results: A paired t‐test on baseline values showed no bias between groups. Both treatments effectively reduced the signs of periodontitis. At each follow‐up visit, reduction in PPD, CAL and BOP after the combined treatment was greater than for SRP alone. Paired t‐tests showed that the improvement in the SRP+gel group was statistically significantly better (p<0.001) than for SRP alone (mean 0.5±0.6 mm. 95% CI 0.4–0.6 mm.) Similarly, the % of sites which improved to a final pocket depth of 3 mm and the % of sites which improved over the 9 months of the study by as much as ≥2 mm were greater for SRP+gel than for SRP alone. Conclusions: At the end of the study, the mean reductions for PPD were 1.0 mm (SRP) compared to 1.5 mm (SRP+gel), and for CAL they were 0.4 mm (SRP) compared to 0.8 mm (SRP+gel), with mean difference for CAL between treatments of 0.4±0.6 mm (95% confidence intervals of 0.3–0.6 mm). The combination therapy of SRP+gel was superior to the conventional treatment of SRP alone, and these differences were maintained for 9 months.
AbstractList Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used adjunctively following such debridement. This 2-centre study compared the clinical effects of subgingival scaling (SRP) with SRP plus subgingival application of 25% metronidazole gel, Elyzol (SRP+gel), in patients with chronic adult periodontitis.BACKGROUND, AIMSConventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used adjunctively following such debridement. This 2-centre study compared the clinical effects of subgingival scaling (SRP) with SRP plus subgingival application of 25% metronidazole gel, Elyzol (SRP+gel), in patients with chronic adult periodontitis.Voluntary informed written consent was obtained from 45 subjects at the Eastman (mean age 46, range 34-63) and 43 subjects at RAF Halton (mean age 47, range 34-71) who participated in this blind, randomised split-mouth design study. All had at least 2 sites in each quadrant with probing pocket depth (PPD) > or = 5 mm. PPD, bleeding on probing (BOP), and clinical probing attachment levels (CAL) measured using a stent, were recorded at baseline and at 1, 3, 6 and 9 months post-therapy. After subgingival scaling of all quadrants, 2 quadrants were randomly selected to be treated with metronidazole gel.METHODVoluntary informed written consent was obtained from 45 subjects at the Eastman (mean age 46, range 34-63) and 43 subjects at RAF Halton (mean age 47, range 34-71) who participated in this blind, randomised split-mouth design study. All had at least 2 sites in each quadrant with probing pocket depth (PPD) > or = 5 mm. PPD, bleeding on probing (BOP), and clinical probing attachment levels (CAL) measured using a stent, were recorded at baseline and at 1, 3, 6 and 9 months post-therapy. After subgingival scaling of all quadrants, 2 quadrants were randomly selected to be treated with metronidazole gel.A paired t-test on baseline values showed no bias between groups. Both treatments effectively reduced the signs of periodontitis. At each follow-up visit, reduction in PPD, CAL and BOP after the combined treatment was greater than for SRP alone. Paired t-tests showed that the improvement in the SRP+gel group was statistically significantly better (p<0.001) than for SRP alone (mean 0.5 +/- 0.6 mm. 95% CI 0.4-0.6 mm.) Similarly, the % of sites which improved to a final pocket depth of < or = 3 mm and the % of sites which improved over the 9 months of the study by as much as > or = 2 mm were greater for SRP+gel than for SRP alone.RESULTSA paired t-test on baseline values showed no bias between groups. Both treatments effectively reduced the signs of periodontitis. At each follow-up visit, reduction in PPD, CAL and BOP after the combined treatment was greater than for SRP alone. Paired t-tests showed that the improvement in the SRP+gel group was statistically significantly better (p<0.001) than for SRP alone (mean 0.5 +/- 0.6 mm. 95% CI 0.4-0.6 mm.) Similarly, the % of sites which improved to a final pocket depth of < or = 3 mm and the % of sites which improved over the 9 months of the study by as much as > or = 2 mm were greater for SRP+gel than for SRP alone.At the end of the study, the mean reductions for PPD were 1.0 mm (SRP) compared to 1.5 mm (SRP+gel), and for CAL they were 0.4 mm (SRP) compared to 0.8 mm (SRP+gel), with mean difference for CAL between treatments of 0.4 +/- 0.6 mm (95% confidence intervals of 0.3-0.6 mm). The combination therapy of SRP+gel was superior to the conventional treatment of SRP alone, and these differences were maintained for 9 months.CONCLUSIONSAt the end of the study, the mean reductions for PPD were 1.0 mm (SRP) compared to 1.5 mm (SRP+gel), and for CAL they were 0.4 mm (SRP) compared to 0.8 mm (SRP+gel), with mean difference for CAL between treatments of 0.4 +/- 0.6 mm (95% confidence intervals of 0.3-0.6 mm). The combination therapy of SRP+gel was superior to the conventional treatment of SRP alone, and these differences were maintained for 9 months.
Background, aims: Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used adjunctively following such debridement. This 2‐centre study compared the clinical effects of subgingival scaling (SRP) with SRP plus subgingival application of 25% metronidazole gel, Elyzol® (SRP+gel), in patients with chronic adult periodontitis. Method: Voluntary informed written consent was obtained from 45 subjects at the Eastman (mean age 46, range 34–63) and 43 subjects at RAF Halton (mean age 47, range 34–71) who participated in this blind, randomised split‐mouth design study. All had at least 2 sites in each quadrant with probing pocket depth (PPD) 5 mm. PPD, bleeding on probing (BOP), and clinical probing attachment levels (CAL) measured using a stent, were recorded at baseline and at 1, 3, 6 and 9 months post‐therapy. After subgingival scaling of all quadrants, 2 quadrants were randomly selected to be treated with metronidazole gel. Results: A paired t‐test on baseline values showed no bias between groups. Both treatments effectively reduced the signs of periodontitis. At each follow‐up visit, reduction in PPD, CAL and BOP after the combined treatment was greater than for SRP alone. Paired t‐tests showed that the improvement in the SRP+gel group was statistically significantly better (p<0.001) than for SRP alone (mean 0.5±0.6 mm. 95% CI 0.4–0.6 mm.) Similarly, the % of sites which improved to a final pocket depth of 3 mm and the % of sites which improved over the 9 months of the study by as much as ≥2 mm were greater for SRP+gel than for SRP alone. Conclusions: At the end of the study, the mean reductions for PPD were 1.0 mm (SRP) compared to 1.5 mm (SRP+gel), and for CAL they were 0.4 mm (SRP) compared to 0.8 mm (SRP+gel), with mean difference for CAL between treatments of 0.4±0.6 mm (95% confidence intervals of 0.3–0.6 mm). The combination therapy of SRP+gel was superior to the conventional treatment of SRP alone, and these differences were maintained for 9 months.
Background, aims: Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used adjunctively following such debridement. This 2‐centre study compared the clinical effects of subgingival scaling (SRP) with SRP plus subgingival application of 25% metronidazole gel, Elyzol ® (SRP+gel), in patients with chronic adult periodontitis. Method: Voluntary informed written consent was obtained from 45 subjects at the Eastman (mean age 46, range 34–63) and 43 subjects at RAF Halton (mean age 47, range 34–71) who participated in this blind, randomised split‐mouth design study. All had at least 2 sites in each quadrant with probing pocket depth (PPD) 5 mm. PPD, bleeding on probing (BOP), and clinical probing attachment levels (CAL) measured using a stent, were recorded at baseline and at 1, 3, 6 and 9 months post‐therapy. After subgingival scaling of all quadrants, 2 quadrants were randomly selected to be treated with metronidazole gel. Results: A paired t ‐test on baseline values showed no bias between groups. Both treatments effectively reduced the signs of periodontitis. At each follow‐up visit, reduction in PPD, CAL and BOP after the combined treatment was greater than for SRP alone. Paired t ‐tests showed that the improvement in the SRP+gel group was statistically significantly better ( p <0.001) than for SRP alone (mean 0.5±0.6 mm. 95% CI 0.4–0.6 mm.) Similarly, the % of sites which improved to a final pocket depth of 3 mm and the % of sites which improved over the 9 months of the study by as much as ≥2 mm were greater for SRP+gel than for SRP alone. Conclusions: At the end of the study, the mean reductions for PPD were 1.0 mm (SRP) compared to 1.5 mm (SRP+gel), and for CAL they were 0.4 mm (SRP) compared to 0.8 mm (SRP+gel), with mean difference for CAL between treatments of 0.4±0.6 mm (95% confidence intervals of 0.3–0.6 mm). The combination therapy of SRP+gel was superior to the conventional treatment of SRP alone, and these differences were maintained for 9 months.
Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used adjunctively following such debridement. This 2-centre study compared the clinical effects of subgingival scaling (SRP) with SRP plus subgingival application of 25% metronidazole gel, Elyzol (SRP+gel), in patients with chronic adult periodontitis. Voluntary informed written consent was obtained from 45 subjects at the Eastman (mean age 46, range 34-63) and 43 subjects at RAF Halton (mean age 47, range 34-71) who participated in this blind, randomised split-mouth design study. All had at least 2 sites in each quadrant with probing pocket depth (PPD) > or = 5 mm. PPD, bleeding on probing (BOP), and clinical probing attachment levels (CAL) measured using a stent, were recorded at baseline and at 1, 3, 6 and 9 months post-therapy. After subgingival scaling of all quadrants, 2 quadrants were randomly selected to be treated with metronidazole gel. A paired t-test on baseline values showed no bias between groups. Both treatments effectively reduced the signs of periodontitis. At each follow-up visit, reduction in PPD, CAL and BOP after the combined treatment was greater than for SRP alone. Paired t-tests showed that the improvement in the SRP+gel group was statistically significantly better (p<0.001) than for SRP alone (mean 0.5 +/- 0.6 mm. 95% CI 0.4-0.6 mm.) Similarly, the % of sites which improved to a final pocket depth of < or = 3 mm and the % of sites which improved over the 9 months of the study by as much as > or = 2 mm were greater for SRP+gel than for SRP alone. At the end of the study, the mean reductions for PPD were 1.0 mm (SRP) compared to 1.5 mm (SRP+gel), and for CAL they were 0.4 mm (SRP) compared to 0.8 mm (SRP+gel), with mean difference for CAL between treatments of 0.4 +/- 0.6 mm (95% confidence intervals of 0.3-0.6 mm). The combination therapy of SRP+gel was superior to the conventional treatment of SRP alone, and these differences were maintained for 9 months.
Author Smart, G. J.
Newman, H. N.
Weiss, G.
Shrowder, J.
Griffiths, G. S.
Bulman, J. S.
Author_xml – sequence: 1
  givenname: G. S.
  surname: Griffiths
  fullname: Griffiths, G. S.
  organization: Department of Periodontology and Clinical Research Centre, Eastman Dental Institute and Hospital for Oral Health Care Sciences, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK
– sequence: 2
  givenname: G. J.
  surname: Smart
  fullname: Smart, G. J.
  organization: Department of Periodontology and Clinical Research Centre, Eastman Dental Institute and Hospital for Oral Health Care Sciences, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK
– sequence: 3
  givenname: J. S.
  surname: Bulman
  fullname: Bulman, J. S.
  organization: Department of Periodontology and Clinical Research Centre, Eastman Dental Institute and Hospital for Oral Health Care Sciences, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK
– sequence: 4
  givenname: G.
  surname: Weiss
  fullname: Weiss, G.
  organization: Department of Periodontology and Clinical Research Centre, Eastman Dental Institute and Hospital for Oral Health Care Sciences, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK
– sequence: 5
  givenname: J.
  surname: Shrowder
  fullname: Shrowder, J.
  organization: Department of Periodontology and Clinical Research Centre, Eastman Dental Institute and Hospital for Oral Health Care Sciences, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK
– sequence: 6
  givenname: H. N.
  surname: Newman
  fullname: Newman, H. N.
  organization: Department of Periodontology and Clinical Research Centre, Eastman Dental Institute and Hospital for Oral Health Care Sciences, University College London, 256 Gray's Inn Road, London, WC1X 8LD, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11140558$$D View this record in MEDLINE/PubMed
BookMark eNqVkU9v0zAchi00xLrBV0A-IG4p_hPHicQFqq2AKkBoMG6W4zidixNntkM7vgnfFoeuPSAOcLLs3_M-lv2egZPe9RqAZxjNMaL5i80cFwhliOHdnCCE5ohwhEmV5rsHYHYYfj0BM0QRzYqKV6fgLIQNQphTSh-BU4xxjhgrZ-DnwnWD9Ca4HroWKmt6o6SFbozKdTrA1lnrtqZfw-i1jJ3u42_wxrtEQtmMNsJBe-Ma10cTTYBbE29gGOt1SpnvSRaScTI4_9fjwY4BdjpOxkb-cFbDtbaPwcNW2qCf3K_n4PPlxdXiTbb6sHy7eLXKVJ6en9G2IWUla9XykmGuGGtr1FBcUkxzyRAra6yKQuoKly2pWsYbkuhcSV6ppqzpOXi-9w7e3Y46RNGZoLS1stduDIITRgjHLIFP78Gx7nQjBm866e_E4TMT8HoPKO9C8LoVykQZTfoXL40VGImpQbERU0lialBMDYpjg2KXJC__kBzv-bf45T6-NVbf_VdWvFt8vDhskyjbi0yIencUSf9NFJxyJq7fL8WyWH25_lRdCUR_AREoync
CitedBy_id crossref_primary_10_1902_jop_2008_070308
crossref_primary_10_1007_s00784_020_03631_8
crossref_primary_10_1111_jcpe_13547
crossref_primary_10_56373_2004_2_5
crossref_primary_10_1016_j_ctim_2007_12_004
crossref_primary_10_1902_jop_2007_070124
crossref_primary_10_1902_jop_2015_130751
crossref_primary_10_3109_10717544_2014_935531
crossref_primary_10_1111_j_1600_051x_2004_00481_x
crossref_primary_10_1902_jop_2007_060221
crossref_primary_10_4103_jicdro_jicdro_70_23
crossref_primary_10_3390_pharmaceutics12111086
crossref_primary_10_1034_j_1601_0825_9_s1_9_x
crossref_primary_10_1002_adma_201900818
crossref_primary_10_1111_j_1600_0757_2009_00315_x
crossref_primary_10_1111_j_1600_0757_2004_03676_x
crossref_primary_10_1016_j_odw_2008_07_001
crossref_primary_10_1016_j_ijbiomac_2018_09_202
crossref_primary_10_3390_pharmaceutics16091108
crossref_primary_10_1016_j_ejpb_2014_05_006
crossref_primary_10_12688_f1000research_140173_1
crossref_primary_10_1016_j_heliyon_2023_e17789
crossref_primary_10_1007_s40496_020_00252_8
crossref_primary_10_1111_j_1600_0757_2004_03677_x
crossref_primary_10_1902_jop_2007_060501
crossref_primary_10_4103_jioh_jioh_292_18
crossref_primary_10_1021_acsomega_4c08967
crossref_primary_10_1155_2024_3113479
crossref_primary_10_1902_jop_2009_090050
crossref_primary_10_1208_s12249_024_02842_6
crossref_primary_10_1016_S0011_8532_02_00030_7
crossref_primary_10_1111_j_1600_0757_2010_00341_x
crossref_primary_10_3390_biom15060903
crossref_primary_10_1111_jcpe_12026
crossref_primary_10_1016_j_actbio_2015_04_009
crossref_primary_10_1007_s00784_012_0685_5
crossref_primary_10_1111_jre_12481
crossref_primary_10_1111_jcpe_13230
crossref_primary_10_1111_j_1600_051X_2005_00879_x
crossref_primary_10_4103_jpbs_jpbs_373_25
crossref_primary_10_1016_j_dentre_2021_100006
crossref_primary_10_1111_prd_12159
crossref_primary_10_1902_jop_2006_050144
crossref_primary_10_1111_prd_12630
crossref_primary_10_1002_jbm_b_30596
crossref_primary_10_14219_jada_archive_2012_0125
crossref_primary_10_1111_cid_13006
crossref_primary_10_24017_science_2023_1_6
ContentType Journal Article
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1034/j.1600-051x.2000.027012910.x
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1600-051X
EndPage 917
ExternalDocumentID 11140558
10_1034_j_1600_051x_2000_027012910_x
JCPE27012910
ark_67375_WNG_G6LVWR9T_0
Genre article
Multicenter Study
Comparative Study
Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
34H
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AHMBA
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CWXXS
D-E
D-F
D-I
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.T
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
UMD
V8K
V9Y
W8V
W99
WBKPD
WBNRW
WIH
WIJ
WIK
WOHZO
WPGGZ
WQJ
WXSBR
XG1
YFH
YOC
YOJ
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
WRC
AAYXX
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7X8
ID FETCH-LOGICAL-c4200-3fd289abcf78517c55fb0d3183134a5058b1c66ae918f29f57d2abc4ca79cd8b3
IEDL.DBID DRFUL
ISICitedReferencesCount 54
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000165359600006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0303-6979
IngestDate Thu Jul 10 23:40:46 EDT 2025
Wed Feb 19 02:33:33 EST 2025
Sat Nov 29 02:54:25 EST 2025
Tue Nov 18 22:33:57 EST 2025
Wed Jan 22 16:58:55 EST 2025
Sun Sep 21 06:15:50 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4200-3fd289abcf78517c55fb0d3183134a5058b1c66ae918f29f57d2abc4ca79cd8b3
Notes istex:80DD40E49F96200EF7E91095E7311EACC3807BE0
ArticleID:JCPE27012910
ark:/67375/WNG-G6LVWR9T-0
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
PMID 11140558
PQID 72522715
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_72522715
pubmed_primary_11140558
crossref_citationtrail_10_1034_j_1600_051x_2000_027012910_x
crossref_primary_10_1034_j_1600_051x_2000_027012910_x
wiley_primary_10_1034_j_1600_051x_2000_027012910_x_JCPE27012910
istex_primary_ark_67375_WNG_G6LVWR9T_0
PublicationCentury 2000
PublicationDate December 2000
PublicationDateYYYYMMDD 2000-12-01
PublicationDate_xml – month: 12
  year: 2000
  text: December 2000
PublicationDecade 2000
PublicationPlace Copenhagen
PublicationPlace_xml – name: Copenhagen
– name: United States
PublicationTitle Journal of clinical periodontology
PublicationTitleAlternate J Clin Periodontol
PublicationYear 2000
Publisher Munksgaard International Publishers
Publisher_xml – name: Munksgaard International Publishers
SSID ssj0017333
Score 1.8419197
SecondaryResourceType review_article
Snippet Background, aims: Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials...
Background, aims: Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials...
Conventional treatment of chronic periodontitis involves mechanical debridement of periodontal pockets. Recently, subgingival antimicrobials have been used...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 910
SubjectTerms adjunctive treatment
Adult
Anti-Infective Agents, Local - therapeutic use
Chronic Disease
Dental Scaling
Double-Blind Method
Female
Glycerides - therapeutic use
Humans
local/topical antimicrobial
Male
metronidazole
Metronidazole - analogs & derivatives
Metronidazole - therapeutic use
Middle Aged
Periodontal Index
Periodontal Pocket - therapy
periodontitis
Periodontitis - drug therapy
Sesame Oil - therapeutic use
Statistics, Nonparametric
subgingival debridement
Treatment Outcome
Title Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel
URI https://api.istex.fr/ark:/67375/WNG-G6LVWR9T-0/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1034%2Fj.1600-051x.2000.027012910.x
https://www.ncbi.nlm.nih.gov/pubmed/11140558
https://www.proquest.com/docview/72522715
Volume 27
WOSCitedRecordID wos000165359600006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1600-051X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017333
  issn: 0303-6979
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VXQRceD_Co_hQcQtNNnGcqAeEtt0itFpVVR97sxzbQYhlU22adsU_4d92xnmgShUCwS2O7Ikz_saesT0zAFsiUwb1cO4rHAI_RmnyFUcrBaGR8sCYNHReridTMZul83l2sAGzzhemiQ_Rb7iRZLj5mgRc5VXrJh43Qp6QVzQP187f5D0aWLSrgjVQpxxiIeIDGO4eTo6n_bmCiJrk8jhx-0kmsjuw1VLc_h29a4vWkPi_vkkjva7guhVq8uB__9tDuN_qquxjA65HsGGXj-HuLt0vohRxT-DnuM9iyMqCdV6WrKzP8Yu2YgWirLzE1ZH1F9pdxSYiL3PBPxjFWkbj2AV3rRhtDLOqzil50lcUA1YhRaJQrm58fbaoK_bdulQ-Rv0oF5Z9sYuncDzZOxp_8ttcD76OCSVRYdD0U7kuBOqAQnNe5IGhCSeMYoVqWpqHOkmUzcK0GGUFF2aEtWOtRKZNmkfPYLAsl_YFMJ6amAxJxFoRJ5FSOhRWZ0EsrFH5KPFgpxtMqdtA6JSPYyHdgXwUk0GE7JfEfkrTiU8d--XaA963PmsCgvxhu3cON30jtfpGl-oEl6ezfbmfTE9OD7MjGXjwtgOWRFGn8xu1tGVdSTFCZRnlyoPnDd5-dQCt2oDz1IMPDlZ_1TP5eXyw1xVf_jOFV3DPhStwV35ew-B8Vds3cFtfIIZWm3BLzNPNViyvAPDvMw4
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zb9QwEB5VXUR54T7CVT9UvAWSTRwn4gGhbbcFlqWqtseb5dgOqrpsqk0DK_4J_5YZ50CVKgSCtySyJ4n9jT0zngNgS2TKoBzOfYVT4MfITb7iqKUgNFIeGJOGLsr1aCKm0_TkJNtfg09dLEyTH6I3uBFnuPWaGJwM0m2ceNxweUJh0TxcuYCTl6hhkVkFW6BQOYgRWQj5wfbB-HDSHyyIqKkujyu3n2Qiuw5bLcVXv6N3adca0ASsrhJJL0u4bosa3_rvP3cbbrbSKnvbwOsOrNnFXdjYJg8jKhJ3D36M-jqGrCxYF2fJyvoCX2krViDOym-4P7Lepd01bHLyMpf-g1G2ZVSPXXrXipFpmFV1TuWTTpERWIUUiUK5vPLx-byu2BfrivkY9b2cW_bZzu_D4XhnNtrz22oPvo4JJ1FhUPlTuS4ESoFCc17kgaElJ4xihYJamoc6SZTNwrQYZgUXZoitY61Epk2aRw9gfVEu7CNgPDUxqZKItgJhoJQOhdVZEAtrVD5MPHjdzabUbSp0qsgxl-5IPopJJcLhlzT8VKgTr7rhlysPeN_7vEkJ8of9Xjjg9J3U8ozc6gSXx9NduZtMjo4PspkMPNjskCWR2ekERy1sWVdSDFFcRs7y4GEDuF8fgHptwHnqwRuHq7_6Mvl-tL_T3T7-ZwqbsLE3-ziRk3fTD0_ghkte4ByAnsL6xbK2z-Ca_op4Wj5vufMnIFE2Fg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zj9MwEB6tWrTwwn2Ua_2w4i2QNHGciAeE2u1yVKVa7fVmObaDVluaqtlAxT_h3zLjHGilFQLBWxLZk8T-xp6xPfMB7IpUGbTDuaewC7wItclTHL0UhEbCfWOSwEW5Hk_FbJacnqbzLfjUxsLU-SG6BTfSDDdek4LblcmbOPGo1vKYwqJ5sHEBJy_Rw6JlFSyBRmU_Il6ZHvTHB5OjabexIMKaXR5Hbi9ORboNu43EV7-Td2nW6lMHbK4ySS9buG6Kmtz67z93G2421ip7W8PrDmzZ5V24PqYTRkQSdw9-jDoeQ1bkrI2zZEV1ga-0JcsRZ8U3nB9Zd6TdFaxz8jKX_oNRtmV0j11615LR0jArq4zok85QEViJEklCsb7y8WpRleyLdWQ-Rn0vFpZ9tov7cDTZOxy98xq2B09HhJMwN-j8qUznAq1AoTnPM9_QkBOEkUJDLckCHcfKpkGSD9OcCzPE0pFWItUmycIH0FsWS_sIGE9MRK4koi2P4lApHQirUz8S1qhsGA_gddubUjep0ImRYyHdlnwYkUuEzS-p-YmoE6_a5pebAfCu9qpOCfKH9V444HSV1PqcjtUJLk9m-3I_nh6fHKSH0h_ATossicpOOzhqaYuqlGKI5jJq1gAe1oD79QHo1_qcJwN443D1V18mP4zme-3t43-WsAPb8_FETt_PPj6BGy53gTv_8xR6F-vKPoNr-ivCaf28Uc6fWQQ1kQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+clinical+outcomes+following+treatment+of+chronic+adult+periodontitis+with+subgingival+scaling+or+subgingival+scaling+plus+metronidazole+gel&rft.jtitle=Journal+of+clinical+periodontology&rft.au=Griffiths%2C+G.+S.&rft.au=Smart%2C+G.+J.&rft.au=Bulman%2C+J.+S.&rft.au=Weiss%2C+G.&rft.date=2000-12-01&rft.pub=Munksgaard+International+Publishers&rft.issn=0303-6979&rft.eissn=1600-051X&rft.volume=27&rft.issue=12&rft.spage=910&rft.epage=917&rft_id=info:doi/10.1034%2Fj.1600-051x.2000.027012910.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_G6LVWR9T_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0303-6979&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0303-6979&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0303-6979&client=summon